CLOs on the Move

Symbiomix Therapeutics

www.symbiomix.com

 
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.symbiomix.com
  • 105 Lock Street Suite 409
    Newark, NJ USA 07103-3576
  • Phone: 609.722.7250

Executives

Name Title Contact Details

Similar Companies

Cole Harbour Place

Cole Harbour Place is a Dartmouth, NS-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

uBiome

uBiome is the leading microbial genomics company. We are pioneering a new era of microbiome-based precision medicine. We allow doctors, patients, and citizen scientists to learn about the human microbiome with unprecedented accuracy and speed.

Discovery Alliance

Discovery Alliance is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Adnexus Therapeutics, Inc.

Adnexus Therapeutics, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Waltham, MA. To find more information about Adnexus Therapeutics, Inc., please visit www.adnexustx.com

VRI

We provide emergency response, fall detection, activity monitoring, medication management, vitals monitoring and care traffic control for over 150,000 clients in all 50 states.